ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Copy number variation analysis of m6A regulators identified METTL3 as a prognostic and immune-related biomarker in bladder cancer

Wang, Xiaoshuai; Yu, Jingwei; Chen, Jinbao; Hou, Yingdong; Du, Zefeng; Huang, Haoyang; Tang, Siqi; Han, Yueyin; Ding, Changhai; Xue, Zhicheng*南方医科大学; 中山大学
Cancer Medicine2021-11DOI: 10.1002/cam4.3981
7被引9阅读
引用收藏
分享

摘要

Purpose Growing evidence has demonstrated an indispensable role for N-6-methyladenosine (m(6)A) in human diseases, but the copy number variations (CNVs) of m(6)A regulatory genes in bladder cancer (BLCA) remains largely unknown. Methods We investigated the CNVs on all known m(6)A regulatory genes using the Cancer Genome Atlas (TCGA) database. The association between CNV events and clinicopathological as well as molecular characteristics of BLCA patients were explored. Gene set enrichment analysis (GSEA) was implemented to reveal relative cellular processes. Association between m(6)A regulatory genes and immune infiltrates was analyzed by The Tumor Immune Estimation Resource (TIMER) database. Results CNV events of m(6)A regulatory genes were frequently observed in BLCA. CNVs of METTL3, METTL14, and METTL16 correlated with molecular characteristics of BLCA patients including TP53 mutation. CNVs of METTL3 associated with the overall survival (OS) of BLCA patients. METTL3 was also associated with several cancer-related cellular processes, including mitotic spindle assembly, G2/M checkpoint, and E2F targets signaling pathway. Besides, the CNVs of m(6)A regulatory genes were correlated with specific kinds of immune infiltrates. Conclusions There are significant correlations between m(6)A regulatory genes with CNVs and clinicopathological characteristics. METTL3 with CNVs were associated with the immune infiltrates and performed as a prognostic marker in BLCA.

学科与关键词

关键词
bladder cancercopy number variationimmune cellsN-6-methyladenosineprognosis
相关
加载中…
  • m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer.
    Li, Zuwei; Li, Yuwu; Zhong, Weizhang; Huang, PeiyuanJournal of Oncology, 2021, 2021: 7488188.
  • m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
    Feng, Zi-Hao; Liang, Yan-Ping; Cen, Jun-Jie; Yao, Hao-Hua; Lin, Hai-Shan; Li, Jia-Ying; Liang, Hui; Wang, Zhu; Deng, Qiong; Cao, Jia-Zheng; Huang, Yong; Wei, Jin-Huan; Luo, Jun-Hang*; Chen, Wei*; Chen, Zhen-Hua*Journal of Translational Medicine, 2022, 20(1): 492.被引 15
  • Classification and immune invasion analysis of breast cancer based on m6A genes
    Qin, Qiang; Fang, Da Lang; Zhou, Weijie; Meng, Yuhua*; Wei, Jie*Annals of Translational Medicine, 2021, 9(18).被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Medicine
发表日期
2021-11
卷期
第 10 卷, 第 21 期
页码
7804-7815
DOI
10.1002/cam4.3981
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • W

    Wang, Xiaoshuai (第一作者)

    southern med univ

  • Y

    Yu, Jingwei

    sun yat sen univ

查看全部 10 位作者收起作者
  • C

    Chen, Jinbao

    sun yat sen univ

  • H

    Hou, Yingdong

    sun yat sen univ

  • D

    Du, Zefeng

    sun yat sen univ

  • H

    Huang, Haoyang

    sun yat sen univ

  • T

    Tang, Siqi

    sun yat sen univ

  • H

    Han, Yueyin

    sun yat sen univ

  • D

    Ding, Changhai

    southern med univ

  • X

    Xue, Zhicheng (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417